1Amending the act of April 14, 1972 (P.L.233, No.64), entitled
2"An act relating to the manufacture, sale and possession of
3controlled substances, other drugs, devices and cosmetics;
4conferring powers on the courts and the secretary and
5Department of Health, and a newly created Pennsylvania Drug,
6Device and Cosmetic Board; establishing schedules of
7controlled substances; providing penalties; requiring
8registration of persons engaged in the drug trade and for the
9revocation or suspension of certain licenses and
10registrations; and repealing an act," further providing for
11schedules of controlled substances.

12The General Assembly of the Commonwealth of Pennsylvania
13hereby enacts as follows:

14Section 1. Section 4(1) of the act of April 14, 1972 (P.L.

15233, No.64), known as The Controlled Substance, Drug, Device and
16Cosmetic Act, is amended by adding a subclause to read:

17Section 4. Schedules of Controlled Substances.--The
18following schedules include the controlled substances listed or
19to be listed by whatever official name, common or usual name,
20chemical name, or trade name designated.

21(1) Schedule I--In determining that a substance comes within
22this schedule, the secretary shall find: a high potential for

1abuse, no currently accepted medical use in the United States,
2and a lack of accepted safety for use under medical supervision.
3The following controlled substances are included in this
4schedule:

5* * *

6(ix) OxyContin and its active ingredient, oxycodone,
7including any isomers, esters and ethers and salts of isomers,
8esters and ethers of OxyContin and oxycodone, whenever the
9existence of such isomers, esters and salts is possible within
10the specific designation, except when used by a person diagnosed
11with a disease or disorder that causes chronic pain.

12* * *

13Section 2. This act shall take effect in 60 days.